The Trump administration is advancing a proposed $2.8 billion arms deal with Israel, supplying advanced munitions despite ongoing international criticism over the country’s military operations, which have been accused of disproportionately affecting civilian populations in the region. The sale includes precision-guided bombs and other weaponry, raising concerns among human rights groups and lawmakers about potential escalation and compliance with international law. Critics argue the deal risks normalizing military actions that have drawn condemnation for their impact on civilian infrastructure and lives. The move comes as tensions in the region remain volatile, with broader implications for U.S. foreign policy and arms export regulations.
Trump administration pushes $2.8bn bomb sale to Israel amid criticism over mass targeting of civilians in the region.
